Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
RDGT · Nasdaq · United States · Retail-Drug Stores And Proprietary Stores
In shortRidgetech Inc. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -1.4% | 12/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -0.9% | 16/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -3.6% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.31× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -27.82× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 1.77 | 17/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -1.1% | 16/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 5 | 20/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 17.7% | 46/100 |
| Operating margin volatility | 3.6% | 76/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -3.9% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
2 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 164 | 149 | 155 | 120 | 132 |
| Cost of revenue | 164 | 149 | 119 | 116 | 127 |
| Gross profit | 37 | 3.6 | 4.9 | 3.8 | 4.8 |
| Operating income | (2.7) | (13) | 0.6 | (1) | (1.9) |
| Interest expense | 0.3 | (0) | (0.2) | (0.1) | 0.1 |
| Pre-tax income | (2.1) | (15) | (0.8) | (1) | (1.3) |
| Income tax | 1.1 | 0.4 | (0) | 0.5 | (0.1) |
| Net income | (3.2) | (21) | (4.2) | 10 | (1.3) |
| Diluted EPS | −$18.35 | −$41.46 | −$439.78 | $275.87 | −$17.21 |
| Diluted shares (millions) | 0.2 | 0.5 | 0 | 0 | 0.1 |
2 older years available with the 10-year history. Essential plan, from €8.25/month →
1.77 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Mar 31, 2026 · Data updated Jul 31, 2026